IfPA’s Patient Access Policy Blog

FDA Plots Progress Toward Biosimilar Access

The Food and Drug Administration is tired of waiting.   Of the 11 biosimilars approved by the agency, only three are available on the U.S.

Read More

Are Medicaid Work Requirements Working?

Work, study, job hunt or volunteer for at least 80 hours a month.  That was Arkansas’ demand to Medicaid recipients as part of the state’s

Read More

New Survey Reveals National Attitudes on Pain Management

What stands between patients and integrative, comprehensive pain management? It could be health plan design, according to a recent attitudinal survey by the Alliance for

Read More

How Gout Hurts All of Us

Treatment is important for the 8 million Americans with gout, a disease caused by uric acid buildup in the body that produces excruciating joint pain.

Read More

Patients Shouldn’t Have to “Fail First”

Imagine having severe eczema. Your hands, arms and feet are always red and irritated. Sometimes your skin is so dry it cracks. Other times you

Read More

Maine Delivers Patient Victory on Non-Medical Switching

In a week already marked by fireworks and parades, patients in Maine have one more thing to celebrate.  A new state law draws clear lines

Read More

The Crossroads of Clinical Trials and Social Media

What can America learn at the crossroads of social media and clinical trials? At a recent National Institutes of Health workshop, one organization had a

Read More

Medicaid Waiver Rejection Signals Win for Patient Access

Massachusetts Medicaid patients are breathing a collective sigh of relief. Federal officials announced this week that Massachusetts will not be allowed to restrict which drugs

Read More

Oregon Expands Access to Hepatitis C Cures

For many patients with an infectious disease, a cure can’t ever be more than a dream.  But for Oregonians living with hepatitis C, that’s changing.

Read More

Is Innovation the Answer to America’s Opioid Epidemic?

The Food and Drug Administration has approved two generic versions of an innovative drug to treat opioid addiction, increasing available treatment options for Americans fighting

Read More
Back to Top